Skip to main content

Advertisement

SpringerLink
Log in

Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Atherosclerosis induces the elevation of uric acid (UA), and an elevated UA level is well known to lead to a poor prognosis in patients with acute heart failure (AHF). However, the prognostic value of atherosclerotic risk factors in hyperuricemic AHF patients remains to be elucidated. The data from 928 patients who were admitted to the intensive care unit (ICU) at Nippon Medical School Chiba Hokusoh Hospital between January 2001 and December 2014, and whose serum UA levels were measured were screened. A total of 394 AHF patients with hyperuricemia were enrolled in this study. The patients were assigned to a low-risk group (≤1 atherosclerosis risk factor) and a high-risk group (≥2 atherosclerosis risk factors) according to their number of risk factors. The patients in the low-risk group were more likely to have dilated cardiomyopathy, clinical scenario 3 than those in the high-risk group. The serum total bilirubin, blood urea nitrogen, C-reactive protein, and brain-type natriuretic peptide levels were significantly higher in the low-risk group than the high-risk group (p < 0.001, p = 0.005, p = 0.003, and p = 0.008, respectively). A multivariate Cox regression model revealed that the number of risk factors (number = 1, HR (hazard ratio) 0.243, 95 % CI 0.096–0.618, p = 0.003; number = 2, HR 0.253, 95 % CI 0.108–0.593, p = 0.002; number ≥3, HR 0.209, 95 % CI 0.093–0.472, p < 0.001), eGFR (per 1.0 mmol/l increase) (HR 0.977, 95 % CI 0.961–0.994, p = 0.007), and serum UA level (per 1 mg/dl increase) (HR 1.270, 95 % CI 1.123–1.435, p < 0.001) was an independent predictor of 1-year mortality. The prognosis, including all-cause death and HF events, was significantly poorer among the low-risk patients than among the high-risk patients. Atherosclerotic risk factors were not associated with a poor prognosis in patients with hyperuricemic AHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102–110

    Article  CAS  Google Scholar 

  2. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, Zhang C (2013) High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One 8:e56864

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Billiet L, Doaty S, Katz JD, Velasquez MT (2014) Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014:852954

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J (2014) Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 16:15–24

    Article  CAS  PubMed  Google Scholar 

  5. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991–1997

    Article  PubMed  Google Scholar 

  6. Huang WM, Hsu PF, Cheng HM, Lu DY, Cheng YL, Guo CY, Sung SH, Yu WC, Chen CH (2016) Determinants and prognostic impact of hyperuricemia in hospitalization for acute heart failure. Circ J 80:404–410

    Article  PubMed  Google Scholar 

  7. Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J (2011) Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail 17:25–30

    Article  PubMed  Google Scholar 

  8. Okazaki H, Shirakabe A, Kobayashi N, Hata N, Shinada T, Matsushita M, Yamamoto Y, Shibuya J, Shiomura R, Nishigoori S, Asai K, Shimizu W (2016) The prognostic impact of uric acid in patients with severely decompensated acute heart failure. J Cardiol. doi:10.1016/j.jjcc.2016.04.013

    Google Scholar 

  9. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968

    Article  PubMed  Google Scholar 

  10. Nieminen MS, Harjola VP (2005) Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 96:5g–10g

    Article  PubMed  Google Scholar 

  11. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847

    Article  PubMed  Google Scholar 

  12. Yamanaka H, Metabolism TG (2012) Essence of the revised guideline for the management of hyperuricemia and gout. Japan Med Assoc J 55:324–329

    PubMed  Google Scholar 

  13. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M, Japan Atherosclerosis Society Committee for E, Clinical Management of A (2007) Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 14:155–158

    Article  CAS  PubMed  Google Scholar 

  14. Mebazaa A, Gheorghiade M, Pina IL, Harjola VP, Hollenberg SM, Follath F, Rhodes A, Plaisance P, Roland E, Nieminen M, Komajda M, Parkhomenko A, Masip J, Zannad F, Filippatos G (2008) Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 36:S129–139

    Article  PubMed  Google Scholar 

  15. Iseki K (2008) Chronic kidney disease in Japan. Intern Med 47:681–689

    Article  PubMed  Google Scholar 

  16. Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H, Investigators JC (2011) Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol 151:143–147

    Article  PubMed  Google Scholar 

  17. Mandviwala T, Khalid U, Deswal A (2016) Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep 18:21

    Article  PubMed  Google Scholar 

  18. Kaul S, Alladi S, Mridula RK, Bandaru SV, Boddu DB, Anjanikumar D, Umamashesh M (2015) Prevalence and risk factors of carotid intima-media thickness in asymptomatic individual subjects in a tertiary care center in India. Ann Indian Acad Neurol 18:430–434

    PubMed  PubMed Central  Google Scholar 

  19. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847

    Article  CAS  PubMed  Google Scholar 

  20. Kondo T, Yamada T, Morita T, Furukawa Y, Tamaki S, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M (2016) The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores. Heart Vessels. doi:10.1007/s00380-016-0861-7

    Google Scholar 

  21. Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M (2016) Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction. Heart Vessels. doi:10.1007/s00380-016-0872-4

    Google Scholar 

  22. Shirakabe A, Hata N, Kobayashi N, Okazaki H, Shinada T, Tomita K, Yamamoto M, Tsurumi M, Matsushita M, Yamamoto Y, Yokoyama S, Asai K, Shimizu W (2015) Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure. Circ J 79:119–128

    Article  PubMed  Google Scholar 

  23. Shirakabe A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, Matsushita M, Okazaki H, Yamamoto Y, Yokoyama S, Asai K, Mizuno K (2013) Prognostic impact of acute kidney injury in patients with acute decompensated heart failure. Circ J 77:687–696

    Article  CAS  PubMed  Google Scholar 

  24. Schrier RW (2006) Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47:1–8

    Article  PubMed  Google Scholar 

  25. Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–585

    Article  CAS  PubMed  Google Scholar 

  26. Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to the staff of the ICU and the medical records office at Nippon Medical School Chiba Hokusoh Hospital for collecting the medical data.

Author information

Authors and Affiliations

  1. Division of Intensive Care Unit (ICU), Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba, 270-1694, Japan

    Hirotake Okazaki, Akihiro Shirakabe, Nobuaki Kobayashi, Noritake Hata, Takuro Shinada, Masato Matsushita, Yoshiya Yamamoto, Yusaku Shibata, Junsuke Shibuya, Reiko Shiomura & Suguru Nishigoori

  2. Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan

    Kuniya Asai & Wataru Shimizu

Authors
  1. Hirotake Okazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiro Shirakabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuaki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noritake Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takuro Shinada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masato Matsushita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshiya Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yusaku Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Junsuke Shibuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Reiko Shiomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Suguru Nishigoori
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kuniya Asai
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Wataru Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akihiro Shirakabe.

Ethics declarations

Funding

This research received no Grants from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors declare no conflicts of interest in association with this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okazaki, H., Shirakabe, A., Kobayashi, N. et al. Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia. Heart Vessels 32, 436–445 (2017). https://doi.org/10.1007/s00380-016-0893-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-016-0893-z

Keywords

Search

Navigation